Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leung, W. K.
Right arrow Articles by Sung, J. J.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leung, W. K.
Right arrow Articles by Sung, J. J.Y.
Related Collections
Right arrow Clinical Intervention
Right arrow Clinical Intervention: Biomarkers
Clinical Cancer Research Vol. 12, 3216-3221, May 15, 2006
© 2006 American Association for Cancer Research

Cancer Prevention

Effects of Helicobacter pylori Eradication on Methylation Status of E-Cadherin Gene in Noncancerous Stomach

Wai K. Leung1, Ellen P.S. Man1, Jun Yu1, Minnie Y.Y. Go1, Ka-fai To1, Yoshio Yamaoka2, Victoria Y.Y. Cheng1, Enders K.W. Ng1 and Joseph J.Y. Sung1

Authors' Affiliations: 1 Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong and 2 Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, and Baylor College of Medicine, Houston, Texas

Requests for reprints: Wai K. Leung, Department of Medicine and Therapeutics, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong. Phone: 852-2632-3140; Fax: 852-2637-3852; E-mail: wkleung{at}cuhk.edu.hk.


   Abstract
Top
 Abstract
Materials and Methods
 Results
 Discussion
 References
 
Purpose: Promoter hypermethylation of E-cadherin plays an important role on gastric cancer development. Whereas E-cadherin methylation was frequently detected in the stomach of Helicobacter pylori–infected individuals, we tested whether eradication of H. pylori alters the methylation status of the noncancerous gastric epithelium.

Experimental Design: Endoscopic biopsies were taken from the antrum and corpus of H. pylori–infected subjects without gastric cancer. Presence of methylated E-cadherin sequences in the gastric specimens was detected by methylation-specific PCR. Bisulfite DNA sequencing was done to determine the topographical distribution and changes in methylation profiles with H. pylori eradication.

Results: Among the 28 H. pylori–infected subjects (median age, 44.5 years), 15 (53.6%) had E-cadherin methylation detected in stomach at baseline. Discordant methylation patterns between the antrum and corpus were noted in six patients. One year after successful H. pylori eradication, there was a significant reduction in the methylation density of the promoter region and exon 1 of the E-cadherin gene as detected by bisulfite DNA sequencing (P < 0.001).

Conclusion: Promoter methylation in E-cadherin was frequently detected in the stomach of H. pylori–infected individuals. Eradication of H. pylori might possibly reduce the methylation density in E-cadherin gene and the chance of subsequent neoplastic transformation.

Epigenetic inactivation of tumor-related genes by promoter hypermethylation is increasingly recognized to play a pivotal role on tumorigenesis (1, 2). Promoter hypermethylation in tumor-related genes is frequently detected in gastric cancer (3, 4) as well as in premalignant gastric lesions (5, 6). Moreover, it is shown that the nonneoplastic gastric mucosa of normal individuals may harbor E-cadherin methylation (7–9).

The E-cadherin gene (CDH1) is located on chromosome 16q22.1, which contains 16 exons. The mature protein product belongs to the family of cell-cell adhesion molecules and plays a fundamental role in the maintenance of cell differentiation and the normal architecture of epithelial tissues. Abrogation of the E-cadherin function induces loss of adherens junctions and impairment of cell adhesiveness and cell proliferation signaling pathways (10). In gastric cancer, loss of function of the E-cadherin gene has been linked to diffuse-type gastric cancer (11). CDH1 mutations are considered to be the commonest somatic alterations in diffuse gastric cancer and germ-line inactivating mutations of CDH1 gene leads to the rare hereditary diffuse gastric cancer syndrome (12). In addition to mutation, epigenetic inactivation of E-cadherin by promoter hypermethylation was frequently reported in sporadic diffuse gastric cancer (13, 14). It is also recently suggested that promoter methylation of E-cadherin in noncancerous gastric epithelium is associated Helicobacter pylori infection (9). It is reported that up to 52.6% of H. pylori–infected noncancer patients have methylated E-cadherin detected in stomach. In contrast, only one of the 15 H. pylori negative patients had methylation in E-cadherin detected.

Although H. pylori is considered to be the most important etiologic agent for gastric carcinoma, the exact mechanism underlying the gastric carcinogenesis remains elusive. It is therefore tempting to test whether eradication of H. pylori could reverse epigenetic changes in the noncancerous gastric epithelium. In this study, we determined the comprehensive methylation profiles of E-cadherin gene in the antrum and corpus of H. pylori–infected individuals without gastric cancer and examined the effects of H. pylori eradication on methylation.


   Materials and Methods
Top
 Abstract
 Materials and Methods
Results
 Discussion
 References
 
Patients and gastric biopsy. Dyspeptic patients referred for upper gastrointestinal endoscopy were recruited. None of these patients took aspirin or nonsteroidal anti-inflammatory drugs. All patients were confirmed to have H. pylori infection by rapid urease test and histology. None of these patients had peptic ulcer or gastric cancer on endoscopy. Gastric mucosal biopsies were obtained during endoscopy according to a standard protocol. Briefly, two biopsies were taken from the lesser curve and greater curve of the antrum and corpus. Gastric biopsies were fixed in buffered formalin and embedded on paraffin for histologic examination and DNA analysis.

All patients were given a 1-week course of anti-Helicobacter therapy consisting of a proton pump inhibitor and two antibiotics after the baseline endoscopy. Clearance of H. pylori infection was confirmed by a negative urea breath test 2 months after the course of antimicrobial therapy. Patients with confirmed H. pylori eradication underwent a follow-up endoscopy at 1 year with biopsy taken as described in baseline endoscopy. All patients were negative for H. pylori by histology on follow-up. The study protocol was approved by the Clinical Research Ethics Committee of the Chinese University of Hong Kong and all patients gave informed written consent for participation in this study.

Histology. Histologic sections of the antrum and the corpus were graded separately for the severity of acute polymorphonuclear infiltrates, chronic mononuclear cell infiltrates, and intestinal metaplasia as stipulated by the updated Sydney system (15). A global score of 0 (none), 1 (mild), 2 (moderate), or 3 (marked) was given for the inflammatory scores.

H. pylori and cell culture. To determine the in vitro effects of H. pylori infection on E-cahderin methylation in gastric epithelial cells, the AGS cell line was cocultured with H. pylori strain TN2GF4, which is positive for cag pathogenecity island and vacA s1 m1 (16). AGS cells were cultured with H. pylori in a six-well plate (multiplicity of infection, 100). Cells were harvested at 12, 24, and 48 hours post H. pylori infection. DNA was extracted for determination of methylation status in E-cadherin gene.

Methylation-specific PCR. Antral and corpus biopsies from the same individual were processed separately. All samples were randomly coded before processing. Genomic DNA was extracted from paraffin-embedded gastric biopsy sections by QIAamp DNA Mini kit (Qiagen, Hilden, Germany) as previously described (17). Presence of methylated E-cadherin DNA in gastric mucosal biopsies was detected by methylation-specific PCR as previously described (18). Briefly, purified DNA samples were chemically modified by sodium bisulfite with the EZ DNA Methylation kit (Zymo Research, Orange, CA) to convert all unmethylated cytosines to uracils while leaving methylcytosines unaltered. The bisulfite-modified DNA was amplified by using primer pairs that specifically amplify either methylated or unmethylated sequences of the E-cadherin genes (17, 18). PCR was done in 25-µL reaction volumes containing 1x PCR buffer [10 mmol/L Tris-HCl (pH 8.3), 50 mmol/L KCl], 2 mmol/L MgCl2, 0.25 mmol/L each of the deoxynucleoside triphosphates (MBI Fermentas), 5 pmol of primer, and 1 unit of AmpliTaq Gold Taq polymerase (Applied Biosystems, Foster City, CA). The condition for amplification was 10 minutes at 95°C followed by 40 cycles of denaturing at 95°C for 45 seconds, 45 seconds of annealing at 57°C, and 1 minute of extension at 72°C. CpGenome Universal methylated DNA (Chemicon International, Inc., CA, USA.) was used as positive control and water was included as negative control during amplification. As a further internal control, three gastric cancer cells (AGS, MKN45, and NCI-N87) with different methylation status in the E-cadherin gene were included.

Bisulfite DNA sequencing. To determine the comprehensive CpG island methylation status of the E-cadherin gene in H. pylori–infected gastric epithelium and the effects of H. pylori eradication, bisulfite DNA sequencing was done in paired gastric biopsies taken from patients before and after H. pylori eradication. PCR primers were designed to amplify the CpG-rich promoter region and exon 1 of the E-cadherin gene (–187 to +177) by using the Methprimer freeware (available at http://www.ucsf.edu/urogene/methprimer/index1.html). The sequences of the primers were forward, 5'-TAGTAATTTTAGGTTAGAGGGTTAA-3', and reverse, 5'-AAATACCTACAACAACAACAACAAC-3'. The 387-bp PCR product, which covered 32 CpG sites, was then cloned into the pCR 2.1-TOPO vector using the TOPO TA Cloning kit (Invitrogen, Carlsbad, CA). At least 10 colonies were selected and grown in LB overnight at 37°C. Plasmid DNA was isolated by QIAprep Miniprep Spin Miniprep Kit (Qiagen) and 2 µL were sequenced using M13 primers and the ABI Prism Dye Terminator Cycle Sequencing Kit (Applied Biosystems) in ABI Prism 3100 DNA Sequencer (Applied Biosystems).

Immunohistochemistry. Expression of E-cadherin in gastric biopsy specimens was examined by immunohistochemistry. Paraffin-embedded sections were dewaxed in xylene and rehydrated in a graded series of ethanol. Microwave antigen retrieval was done in citrate buffer (pH 6.0) for 10 minutes before peroxidase quenching with 3% H2O2 in methanol for 10 minutes. Primary antibody against E-cadherin (Zymed Laboratories, San Francisco, CA) was applied and incubated at 1:100 dilution for 2 hours at room temperature. Biotinylated second antibody and enzyme conjugate (Histostain-Plus Kits; Zymed Laboratories) were incubated for 45 minutes each. 3,3'-Diaminobenzidine was then added and incubated until chromogen developed. Percentage of gastric epithelial cells with loss of E-cadherin expression was computed by counting >500 representative cells in at least 10 different fields.

Statistical analysis. Statistical analysis was done with SPSS software (ver. 11.0; SPSS, Chicago, IL). {chi}2 test or Fisher's exact test was used for analysis of categorical data. Numerical data were analyzed by Student's t test. Wilcoxon signed-rank test was used for paired comparison of methylation frequency before and after H. pylori eradication. Two-sided P < 0.05 was considered to be statistically significant.


   Results
Top
 Abstract
 Materials and Methods
 Results
Discussion
 References
 
Patients. Gastric biopsies from 28 H. pylori–infected patients (male 42.9%; median age, 44.5 years; range, 34-55 years) were available for analysis. Ten (35.7%) patients had history of gastric cancer in first-degree relatives. The severity of gastric inflammation was listed in Table 1 . Moreover, 18 of them had intestinal metaplasia on microscopic examination (16 in antrum only, 1 in corpus only, and 1 in both antrum and corpus). Among the 28 patients, 25 had serial gastric biopsies taken before and 1 year after H. pylori eradication. Intestinal metaplasia was still detectable in 15 patients 1 year after H. pylori eradication (12 in antrum only, 1 in corpus only, and 2 in both antrum and corpus).


View this table:
[in this window]
[in a new window]
  		Table 1. Patients' characteristics, gastric inflammation score, and E-cadherin methylation status

 
Promoter methylation of E-cadherin gene in normal gastric epithelium. At baseline, gastric biopsies from 15 (53.6%) H. pylori–infected patients had methylation detected. Specifically, 14 (50%) antral and 10 (35.7%) corpus biopsies were positive for methylated E-cadherin sequences. Six (21.4%) patients had discordant methylation results in the antrum and corpus at baseline (Table 1).

Serial gastric biopsies were available from 25 patients after H. pylori eradication. There was a considerable dynamic change in the methylation-specific PCR results after H. pylori eradication (Table 1). As shown in Fig. 1 , there was a mild and nonsignificant reduction in the number of methylation-specific PCR positive gastric samples after H. pylori eradication.


Figure 1
View larger version (21K):
[in this window]
[in a new window]
  		Fig. 1. Changes in the number of gastric samples with positive methylation-specific PCR after H. pylori eradication.

 
Bisulfite DNA sequencing. In addition to methylation-specific PCR, we did bisulfite DNA sequencing in a subset of randomly selected samples to determine the comprehensive methylation pattern of individual CpG islands in the E-cadherin gene. We randomly selected seven sets of paired antral and corpus biopsies taken from patients before and after H. pylori eradication (Fig. 2 ). The NCI-N87 gastric cancer cell with methylated E-cadherin gene was used as positive control whereas the two gastric cancer cell lines, AGS and MKN45, were used as negative control. The results of the methylation-specific PCR and bisulfite DNA sequencing are highly concordant (Fig. 2). All methylation-specific PCR positive samples had methylated CpG islands detected on bisulfite DNA sequencing.


Figure 2
View larger version (41K):
[in this window]
[in a new window]
  		Fig. 2. Bisulfite DNA sequencing. Bisulfite DNA sequencing was done in three gastric cancer cell lines (NCI-N87, AGS, and MKN45) and seven sets of serial antral and corpus biopsies taken from patients before and after H. pylori eradication. Results of bisulfite DNA sequencing in AGS cell line after coculture with H. pylori for up to 48 hours. Each circle represented a single CpG site and the density of methylation was indicated by the color changes. Pre, baseline; post, after H. pylori eradication; MSP, methylation-specific PCR; +, positive; –, negative; HP, H. pylori.

 
Three patterns of methylation changes were noted after H. pylori eradication: no change, decrease, and increase in methylation density. The most common pattern was seen in sample no. 2, the antrum of sample no. 19, and the corpus of sample nos. 9, 17, and 18, in which both the extent and density of methylation decrease with H. pylori eradication. On the other hand, the extent and density of methylation were mildly increased in sample no. 1, the antrum of sample nos. 17 and 18, and the corpus of sample no. 19. There was no change in methylation pattern and density of sample no. 20. Overall, H. pylori eradication resulted in a significantly reduction in mean methylation density of the E-cadherin gene in both the promoter region and exon 1 (P < 0.0001; Fig. 3 ).


Figure 3
View larger version (10K):
[in this window]
[in a new window]
  		Fig. 3. Changes in methylation density of the E-cadherin exon 1 and promoter region after H. pylori eradication. Columns, mean methylation density in the promoter region and exon 1 of the E-cadherin gene after H. pylori eradication; bars, SE. There was a significant reduction in the methylation density of the promoter region and exon 1 after H. pylori eradication (P < 0.001). HP+, baseline; HP–, post H. pylori eradication.

 
Methylated E-cadherin and gastric inflammation. We also determined the correlation between gastric inflammation and E-cadherin methylation. Both acute and chronic inflammatory scores were significantly higher in gastric biopsies with methylation in E-cadherin gene. The mean acute and chronic inflammatory scores were 0.88 and 1.48 in gastric biopsies with methylated E-cadherin whereas the corresponding scores were 0.42 (P = 0.013) and 0.98 (P = 0.003) in biopsies without methylation. Promoter hypermethylation was detected in 43.2% of gastric biopsies with intestinal metaplasia and 37.5% of gastric biopsies without intestinal metaplasia (P = 0.67). There was no association between promoter hypermethylation of E-cadherin gene and age of patients (antrum, P = 0.35; corpus, P =0.90). There is also no association between E-cadherin methylation and family history of gastric cancer.

E-cadherin expression and methylation. The localization of E-cadherin expression was detected by immunohistochemistry (Fig. 4 ). Membranous expression of E-cadherin was detected at the basolateral border of normal glandular and foveolar epithelial cells. Despite the presence of E-cadherin methylation, there was no complete loss of E-cadherin expression in these noncancerous gastric mucosal specimens. There was, however, a tendency towards a higher percentage of partial loss of E-cadherin expression in gastric biopsies containing intestinal metaplasia. The percentage loss of E-cadherin expression was significantly higher in the glandular epithelium of gastric biopsies containing intestinal metaplasia than those without intestinal metaplasia (median, 10% versus 5%; P = 0.034). Similar tendency was observed in the foveolar epithelium (P = 0.05).


Figure 4
View larger version (98K):
[in this window]
[in a new window]
  		Fig. 4. E-cadherin expression in gastric epithelium. A, membranous expression of E-cadherin in normal gastric epithelium. B, mild reduction in E-cadherin immunoreactivity in foci with intestinal metaplasia. Stain, E-cadherin antibody. (Original magnification, A, x200, B, x400).

 
Effect of transient H. pylori infection on E-cadherin methylation. To further test the effect of H. pylori infection on gastric cells, we determined the methylation changes in AGS gastric cells after coculture with H. pylori for up to 48 hours. Methylated E-cadherin DNA was, however, not detected in AGS cells by both methylation-specific PCR and bisulfite DNA sequencing after coculture with H. pylori (Fig. 2).


   Discussion
Top
 Abstract
 Materials and Methods
 Results
 Discussion
References
 
In this study, we focused on H. pylori–associated gastritis, the early stage of the gastric carcinogenesis cascade. Although promoter hypermethylation of E-cadherin gene in the noncancerous gastric epithelium has previously been reported (5–9), the topographical methylation pattern in different parts of the stomach has not been properly evaluated. Among the 28 paired gastric biopsies taken from the antrum and corpus of H. pylori–infected individuals, we found that 53.6% of patients had methylation in E-cadherin gene as detected by methylation-specific PCR. This frequency was comparable to previous reports in noncancerous biopsies (6, 9). Interestingly, discordant methylation patterns were noted in the antrum and corpus of patients with H. pylori–associated gastritis. The frequency of methylation tended to be higher in the antrum than in the corpus (50% versus 35.7%) although the difference did not reach statistical significance. The bisulfite DNA sequencing results further confirmed the discrepant methylation patterns between the antrum and corpus.

We further determined the role of H. pylori eradication on the methylation pattern of E-cadherin gene in the noncancerous gastric epithelium by both methylation-specific PCR and bisulfite DNA sequencing. One year after H. pylori eradication, there was a marked reduction in the methylation density as detected by the comprehensive bisulfite DNA sequencing. The methylation density dropped significantly in the promoter region and exon 1 of the E-cadherin gene (Fig. 3). Our findings are therefore in support of the potential beneficial effects of H. pylori eradication on the reversal of E-cadherin promoter hypermethylation. On the other hand, there was no significant difference on the numbers of methylated gastric samples after H. pylori eradication by the extremely sensitive methylation-specific PCR. In this regard, bisulfite DNA sequencing may provide a better delineation of subtle methylation changes after clearance of H. pylori, which could not be provided by qualitative methylation-specific PCR alone.

Whereas the triggering event leading to promoter hypermethylation of E-cadherin in the noncancerous stomach remains elusive, it is strongly believed that environmental factors, particularly chronic H. pylori infection, play an important role (19). It is highly plausible that the direct effects of H. pylori or the adaptive response of the host to the chronic inflammation triggers the development of these epigenetic changes in noncancerous stomach, which eventually lead to neoplastic transformation. However, we failed to show any increase in methylation of the CpG islands of the E-cadherin gene in AGS gastric cells after short-term coculture of H. pylori. It may be necessary to determine the effects of H. pylori on methylation changes in longer-term experiments. However, our findings are in favor of the potential beneficial effects of H. pylori eradication by eliminating the possible drive to methylation changes. In keeping with this finding, we have previously shown that eradication of H. pylori infection reverses the aberrant expression of cyclin D2 and p27 in intestinal metaplasia (20).

Epigenetic inactivation in the stomach is likely to be multifocal in nature, which may be related to the severity of inflammation. In this study, we have shown a significant correlation between acute and chronic inflammation scores and the presence of methylated E-cadherin genes. This may also partly explain the disparate methylation pattern between the antrum and corpus of the stomach. Despite the presence of methylated E-cadherin sequences, there was no apparent loss of E-cadherin expression in most noncancerous gastric epithelium as detected by immunohistochemistry (Fig. 4). This could be explained by the extremely sensitive methylation-specific PCR which can detect a small subpopulation of cells showing these abnormalities. In contrast, a partial loss of E-cadherin expression was more commonly detected in gastric intestinal metaplasia, a presumed preneoplastic gastric lesion. Similar observation was made in past studies which reported loss of E-cadherin expression in intestinal metaplasia as well as in early gastric cancer (21, 22).

Although previous studies have suggested the detection of E-cadherin methylation in normal gastric and bladder epithelium of aged patients (9, 23), we failed to show any significant association between promoter hypermethylation and age in this study. This may be related to the recruitment of relatively young patients (median age, 44.5 years) in this study. However, it may be more difficult to show any potential effects of H. pylori eradication in elderly patients with advanced histologic and possibly epigenetic changes. In addition, further studies may be necessary to characterize the methylation changes in patients with early gastric cancer, particularly the role of H. pylori eradication in those who received endoscopic treatment. However, early gastric cancer is an uncommon disease in this locality and most of our patients are treated with surgical resection, which made these specimens unavailable for analysis in the present study.

In conclusion, we have shown the comprehensive methylation pattern in noncancerous stomach of H. pylori–infected individuals. In addition to the demonstration of a discordant methylation pattern between the antrum and corpus, we have shown that eradication of H. pylori resulted in a significant reduction in methylation density of the noncancerous stomach. The result is therefore in favor of the potential beneficial effect of H. pylori eradication on regression of epigenetic changes in the noncancerous stomach and possibly on chemoprevention of cancer.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 11/ 9/05; revised 1/14/06; accepted 1/25/06.


   References
Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

  1. Laird PW. Cancer epigenetics. Hum Mol Genet 2005;14:R65–76.[Abstract/Free Full Text]
  2. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005;6:597–610.[CrossRef][Medline]
  3. Leung WK, Yu J, Ng EK, et al. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 2001;91:2294–301.[CrossRef][Medline]
  4. Lee TL, Leung WK, Chan MW, et al. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 2002;8:1761–6.[Abstract/Free Full Text]
  5. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001;61:2847–51.[Abstract/Free Full Text]
  6. To KF, Leung WK, Lee TL, et al. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 2002;102:623–8.[CrossRef][Medline]
  7. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S, Motoyama T. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol 2002;161:399–403.[Abstract/Free Full Text]
  8. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 2003;163:1551–6.[Abstract/Free Full Text]
  9. Chan AO, Lam SK, Wong BC, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003;52:502–6.[Abstract/Free Full Text]
  10. Berx G, Becker KF, Hofler H, van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998;12:226–37.[CrossRef][Medline]
  11. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994;54:3845–52.[Abstract/Free Full Text]
  12. Guilford PJ, Hopkins JB, Grady WM, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999;14:249–55.[CrossRef][Medline]
  13. Tamura G, Yin J, Wang S, et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 2000;92:569–73.[Abstract/Free Full Text]
  14. Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001;20:1525–8.[CrossRef][Medline]
  15. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161–81.[CrossRef][Medline]
  16. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998;115:642–8.[CrossRef][Medline]
  17. Bai AH, Tong JH, To KF, et al. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. Int J Cancer 2004;112:846–53.[CrossRef][Medline]
  18. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821–6.[Abstract/Free Full Text]
  19. Graziano F, Humar B, Guilford P. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol 2003;14:1705–13.[Abstract/Free Full Text]
  20. Yu J, Leung WK, Ng EK, et al. Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia. Aliment Pharmacol Ther 2001;15:1505–11.[CrossRef][Medline]
  21. Mingchao, Devereux TR, Stockton P, et al. Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis. Exp Toxicol Pathol 2001;53:237–46.[CrossRef][Medline]
  22. Blok P, Craanen ME, Dekker W, Tytgat GN. Loss of E-cadherin expression in early gastric cancer. Histopathology 1999;34:410–5.[Medline]
  23. Bornman DM, Mathew S, Alsruhe J, Herman JG, Gabrielson E. Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 2001;159:831–5.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 INT J SURG PATHOLHome page
Y.-F. Zhao, Y.-G. Zhang, X.-X. Tian, Juan Du, and Jie Zheng
Aberrant Methylation of Multiple Genes in Gastric Carcinomas
International Journal of Surgical Pathology, July 1, 2007; 15(3): 242 - 251.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
R. M. Peek Jr., B. G. Schneider, and P. Correa
Coming unglued.
Clin. Cancer Res., May 15, 2006; 12(10): 2951 - 2954.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leung, W. K.
Right arrow Articles by Sung, J. J.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leung, W. K.
Right arrow Articles by Sung, J. J.Y.
Related Collections
Right arrow Clinical Intervention
Right arrow Clinical Intervention: Biomarkers

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online